Influx Healthtech Limited (NSE:INFLUX)

India · Delayed Price · Currency is INR

256.00

-4.20 (-1.61%)

At close: Oct 1, 2026

Market Cap	5.93B +50.2%
Revenue (ttm)	1.47B +46.9%
Net Income	205.39M +84.6%
EPS	9.35 +52.5%
Shares Out	23.15M
PE Ratio	27.39
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	49,200
Open	260.05
Previous Close	260.20
Day's Range	240.00 - 260.05
52-Week Range	160.60 - 315.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 4, 2026

About Influx Healthtech

Influx Healthtech Limited engages in development and manufacturing of healthcare products in India. It provides dietary and nutritional supplements in the form of tablets, capsules, soft gels, liquid orals, oral powders, lozenges, jellies, effervescent tablets, and gummies; and cosmetics and personal care formulations, such as creams, gels, external oils, and soaps; ayurvedic and herbal products; veterinary feed supplements; and homecare items. The company also exports its products. Influx Healthtech Limited was founded in 2003 and is based in ... [Read more]

Industry Medicinal Chemicals and Botanical Products

Founded 2003

Employees 278

Stock Exchange National Stock Exchange of India

Ticker Symbol INFLUX

Full Company Profile

Financial Performance

In fiscal year 2026, Influx Healthtech's revenue was 1.47 billion, an increase of 40.04% compared to the previous year's 1.05 billion. Earnings were 205.39 million, an increase of 53.66%.

Financial Statements